TYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Sandoz Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: fe49da9a3cb0934b
Drug Cima Aemps Name: TYRUKO 300 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1231745001
Holder Company Name: Sandoz Gmbh
Marketing Company Name: Sandoz Farmaceutica S.A.
Holder Company Detail Path: /organization/sandoz-gmbh
Authorization Date: 2023-09-29
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Sandoz Gmbh
Company Detail Path: /organization/sandoz-gmbh

NATALIZUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 29, 2023

Approval ID

fe49da9a3cb0934b

Type

Standard